Navigation Links
Virtify Delivers SaaS Clinical Trial Disclosure Solution for Mid-Market Life Sciences Companies

CAMBRIDGE, Mass., Sept. 9 /PRNewswire/ -- Virtify, Inc., the market leader in enterprise content compliance software solutions for life sciences companies, today announced the availability of a new, Software-as-a-Service (SaaS) solution for managing clinical trial disclosure requirements. The Virtx Clinical Trial Registry & Results solution (Virtx CTRR) is a robust offering that automates compliance with global regulatory mandates and delivers rapid ROI by delivering best practices in regulatory information processing and eliminating upfront investments in hardware, software and implementation services.

New, evolving laws and mandates from global regulatory bodies and international health organizations such as the US FDA, World Health Organization, FDAAA, India CTRI, and the EMEA Authority, have dramatically increased public disclosure requirements for clinical trials and their results. As these authorities expand the requirements, e.g. the FDA's new adverse events reporting requirement effective September 27(th) 2009, many life sciences companies find themselves ill-equipped to comply due to manual or out-of-date systems. Without the proper processes and technology in place, companies run the risk of costly delays, penalties and lost market opportunities. This is especially true for small and mid-sized life sciences companies that lack the adequate internal staff and resources to achieve compliance.

Virtify's new SaaS CTRR solution helps mid-size life sciences organizations comply with the new regulations in a consistent, efficient and predictable manner. The software automates internal workflow and data gathering processes, as well as external workflow with various global regulatory agencies. With its SaaS-based delivery, the Virtx CTRR solution is also able to maintain compliance with all new and emerging regulatory mandates, reducing risk, and insulating business users from the complexity of changing compliance requirements. At the same time, life sciences companies can maintain complete control of their clinical trial disclosure processes - just as they would with an in-house software solution - but at a fraction of the overall cost of ownership.

"Clinical trial sponsors of all sizes must take stock of their existing business processes and systems to ensure that accurate and compliant communication of clinical trial data is available in the public domain," said Dr. Satish Tadikonda, president and founder of Virtify. "Our SaaS-based CTRR solution enables life sciences companies of all sizes to address this challenge by managing the entire clinical trial disclosure life cycle more efficiently and cost-effectively."

Virtify's Virtx Clinical Trial Registry & Results Solution - Key Features and Capabilities

  • Collaborative, web-based environment for managing clinical trial disclosure
  • Complete lifecycle management of the disclosure process from internal review, through approvals, postings, and results maintenance
  • Ease-of-use and intuitive interface promoting greater user adoption
  • Internal workflow management and automation for improved processes and quality
  • External workflow management with regulatory agencies for improved accuracy and consistency
  • Unique submissions comparison/reconciliation feature for greater speed and efficiency
  • Up-to-date compliance with current & emerging global regulations and standards:
  • US FDA, WHO, FDAAA, CTRI, EMEA, and other authorities
  • Compliant with FDA 21 CFR and SAE/AE reporting
  • Robust validation, auditing, security, and authentication
  • Integrated search, reporting and progress monitoring
  • SaaS delivery for rapid ROI

Virtify also offers comprehensive professional services to further optimize Clinical Trial Disclosure initiatives including:

  • business process optimization to align with new standards;
  • custom implementation and data migration;
  • product and standards training; and
  • product and technical support

Virtx Enterprise Content Compliance (ECC) Software Suite

Virtx CTRR is part of the Virtify Virtx ECC Software Suite, an end-to-end, Web-based solution for managing content and compliance requirements for life sciences companies. Unlike traditional content management solutions or individual point products, the Virtx software suite provides a secure, collaborative online environment for managing regulated content throughout the entire life sciences product continuum.

About Virtify

Virtify is the market leader in Enterprise Content Compliance software solutions for life sciences. Organizations rely on Virtify solutions to reduce time-to-market, risk, and costs by managing and automating the complex regulatory compliance and content exchange requirements throughout the product life cycle. Virtify's easy-to-use Virtx software suite is the industry's only solution to provide a secure, collaborative web-based environment for managing regulated content throughout the entire continuum -- from pre-clinical through product registration to commercialization. The company plays a leadership role in the development of global regulatory standards and is an active participant in a variety of standards committees. Virtify's software products combined with comprehensive professional services and deep domain expertise enhance quality and compliance for some of the world's leading life sciences companies. Located on the Web at

SOURCE Virtify, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Building on Growth, Virtify Adds to Executive Team and Expands Commercial Operations
2. AARP Delivers Health Care Reform Message in a Bottle to Cong. Hare
3. California Walnut Industry Delivers High-Quality Crop
4. AARP Delivers Strong Health Care Reform Message in a Bottle to Members of Congress
5. Connecticut Cigarette Tax Increase Delivers Victory for Kids and Taxpayers; $1 Increase Gives State Second Highest Cigarette Tax in the Nation
6. Tosoh Delivers New Immunoassay Analyzer and Educational Seminars at AACC Meeting
7. Energy-X Lip Balm Delivers Wake-Up Call to Consumers
8. Veracord Delivers FDA Expertise with SyberWorks Latest Learning Management Solution
9. District of Columbia Cigarette Tax Increase Delivers Victory for Kids and Taxpayers
10. Electronic Forms Management Suite from Access Delivers Admissions Efficiency at Laughlin Memorial Hospital
11. Narconon Graduate Delivers Drug Education in Florida
Post Your Comments:
(Date:6/25/2016)... ... June 25, 2016 , ... ... and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the Hynes ... important health care topics including advance care planning, healthcare costs and patient and ...
(Date:6/25/2016)... Long Beach, CA (PRWEB) , ... June 25, 2016 , ... ... from UCLA with Magna Cum Laude and his M.D from the David Geffen School ... San Diego and returned to Los Angeles to complete his fellowship in hematology/oncology at ...
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced traumatic events may ... to unhealthy avenues, such as drug or alcohol abuse, as a coping mechanism. To ... for healthy coping following a traumatic event. , Trauma sufferers tend to feel a ...
(Date:6/24/2016)... Francisco, CA (PRWEB) , ... June 24, 2016 ... ... CitiDent, is now offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive ... self-ligating Damon brackets , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... is proud to recognize Dr. Barry M. Weintraub as a prominent plastic surgeon ... beautiful women in the world, and the most handsome men, look naturally attractive. ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... June 24, 2016   Bay Area Lyme ... Dean Center for Tick Borne Illness , ... Rehabilitation, MIT Hacking Medicine, University of California, Berkeley, ... announced the five finalists of Lyme Innovation ... More than 100 scientists, clinicians, researchers, entrepreneurs, and ...
(Date:6/24/2016)... Va. , June 24, 2016 The ... set of recommendations that would allow biopharmaceutical ... (HCEI) with entities that make formulary and coverage decisions, ... the "value" of new medicines. The recommendations ... does not appear on the drug label, a prohibition ...
(Date:6/24/2016)... , June 24, 2016 Research ... World Market for Companion Diagnostic Tests" report to their ... Market for Companion Diagnostics The World Market ... and personalized medicine diagnostics. Market analysis in the report includes ... Test Market (In Vitro Diagnostic Kits) by Region (N. America, ...
Breaking Medicine Technology: